Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Reflects Down Week for the Market

The BCW Index dropped 2.8 percent for the week ended Tuesday, mirroring a decline in the market. The Dow Jones finished the tracking period down 2.7 percent, while the Nasdaq fell 4.2 percent, and the Nasdaq Biotech Index dropped 3.8 percent.

In total, 14 of the 16 companies in the Index saw their stocks fall over the past week. Agilent led decliners with a fall of 7.6 percent. Shares of Applied Biosystems, Bruker BioSciences, Molecular Devices, and Qiagen all lost more than 5 percent. Meanwhile, Harvard Bioscience and PerkinElmer were the only two that gained in value during the week.

BioCommerce Week Index of
Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(
June 13, 2006)
Last Price
(
June 6, 2006)
% Change
Agilent
A
31.45
34.04
-7.6
Applied Biosystems
ABI
28.84
30.52
-5.5
Beckman
BEC
52.88
55.07
-4.0
Bio-Rad
BIO
64.40
65.31
-1.4
Bruker
BRKR
4.97
5.31
-6.4
Fisher Scientific
FSH
71.29
73.75
-3.3
GE
GE
33.73
34.55
-2.4
Harvard Bio
HBIO
4.16
4.10
1.5
Invitrogen
IVGN
63.87
64.24
-0.6
Molecular Devices
MDCC
27.85
29.40
-5.3
PerkinElmer
PKI
20.55
20.15
2.0
Qiagen
QGEN
12.98
13.80
-5.9
Sigma
SIAL
68.89
69.14
-0.4
Stratagene
STGN
5.85
6.08
-3.8
Thermo
TMO
35.60
36.81
-3.3
Waters
WAT
41.82
43.54
-4.0
BCW Index Average  
35.57
36.61
-2.8
The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.